Prediction of CKD progression and cardiovascular events using albuminuria and pulse wave velocity

Prediction of CKD progression and cardiovascular events using albuminuria and pulse wave velocity

Introduction: Chronic kidney disease (CKD) is associated with cardiovascular disease (CVD) and death. Albuminuria is an established risk factor, but additional biomarkers predicting CKD progression or CVD are needed. Arterial stiffness is an easily measurable parameter that has been associated with...

Full description

Bibliographic Details
Main Authors:	Rasmus Kirkeskov Carlsen, Dinah Sherzad Khatir, Danny Jensen, Henrik Birn, Niels Henrik Buus
Format:	Article
Language:	English
Published:	Karger Publishers 2023-06-01
Series:	Kidney & Blood Pressure Research
Online Access:	https://beta.karger.com/Article/FullText/530887

Similar Items

Employment of patients with kidney failure treated with dialysis or kidney transplantation—a systematic review and meta-analysis
by: Lilli Kirkeskov, et al.
Published: (2021-10-01)

P59 ARTERIAL STIFFNESS AND PERIPHERAL VASCULAR RESISTANCE IN OFFSPRING OF HYPERTENSIVE PARENTS – INFLUENCE OF GENDER AND OTHER CONFOUNDERS
by: Niels Henrik Buus, et al.
Published: (2017-12-01)

Can patiromer allow for intensified renin–angiotensin–aldosterone system blockade with losartan and spironolactone leading to decreased albuminuria in patients with chronic kidney disease, albuminuria and hyperkalaemia? An open-label randomised controlled trial: MorphCKD
by: Henrik Birn, et al.
Published: (2022-02-01)

Estimated pulse wave velocity and cardiovascular events in Chinese
by: Chunpeng Ji, et al.
Published: (2020-12-01)

Urinary Dipstick Is Not Reliable as a Screening Tool for Albuminuria in the Emergency Department—A Prospective Cohort Study
by: Christian B. Nielsen, et al.
Published: (2022-02-01)

Renal Function, Albuminuria, and the Risk of Cardiovascular Events After Kidney Transplantation
by: Ngan N. Lam, MD, MSc, et al.
Published: (2018-10-01)

Integrated approach of brachial-ankle pulse wave velocity and cardiovascular risk scores for predicting the risk of cardiovascular events.
by: Hyue Mee Kim, et al.
Published: (2022-01-01)

Estimated Pulse Wave Velocity Is Associated With All‐Cause Mortality During 8.5 Years Follow‐up in Patients Undergoing Elective Coronary Angiography
by: Esben Laugesen, et al.
Published: (2022-05-01)

8. USEFULNESS OF BRACHIAL-ANKLE AND CAROTID-FEMORAL PULSE WAVE VELOCITY AS PREDICTIVE VALUES OF CARDIOVASCULAR EVENTS
by: Takashi Takagi, et al.
Published: (2009-10-01)

Combining Pulse Wave Velocity With Galectin-3 to Predict Mortality and Cerebrovascular and Cardiovascular Events in Hemodialysis Patients
by: Qi Zhang, et al.
Published: (2020-10-01)

11.7 AORTIC CALCIUM SCORE AFFECTS NON-INVASIVELY OBTAINED ESTIMATES OF CENTRAL BLOOD PRESSURE IN PATIENTS WITH ADVANCED CHRONIC KIDNEY DISEASE
by: Rasmus K. Carlsen, et al.
Published: (2016-11-01)

Albuminuria: An Underappreciated Risk Factor for Cardiovascular Disease
by: Joshua I Barzilay, et al.
Published: (2024-01-01)

P16 PULSE WAVE VELOCITY AND ITS ASSOCIATION WITH FIRST CARDIOVASCULAR EVENTS IN A PORTUGUESE HYPERTENSIVE SAMPLE
by: Clarinda Neves, et al.
Published: (2018-12-01)

Apolipoprotein B, triglyceride-rich lipoproteins, and risk of cardiovascular events in persons with CKD
by: Lamprea-Montealegre, J, et al.
Published: (2019)

P11 Creatinine level and albuminuria and their association with cardiovascular events un type 2 diabetics patients
by: Guillermo Dieuzeide, et al.
Published: (2020-11-01)

YKL-40 levels are independently associated with albuminuria in type 2 diabetes
by: Vestergaard Henrik, et al.
Published: (2011-06-01)

P10.14 AORTIC PULSE WAVE VELOCITY IS AN INDEPENDENT CARDIOVASCULAR EVENT PREDICTOR IN HIGH CARDIOMETABOLIC RISK GROUP
by: R. Navickas, et al.
Published: (2014-11-01)

P84 Prediction of Cardiovascular Events and Mortality by Pulse Wave Velocity: a Comparison of Invasive Measurements and Noninvasive Estimation Methods
by: Bernhard Hametner, et al.
Published: (2020-02-01)

Patients with type 1 diabetes and albuminuria have a reduced brain glycolytic capability that is correlated with brain atrophy
by: Mark B. Vestergaard, et al.
Published: (2023-10-01)

Plasma trimethylamine N-oxide and its metabolic precursors and risk of mortality, cardiovascular and renal disease in individuals with type 2-diabetes and albuminuria.
by: Signe Abitz Winther, et al.
Published: (2021-01-01)

Accurate method for measuring arterial pulse wave velocity by cardiovascular magnetic resonance
by: Ibrahim El-Sayed
Published: (2012-02-01)

PULSE WAVE VELOCITY AND ENDOTHELIAL FUNCTION COMPARISON IN HEALTHY PEOPLE AND CARDIOVASCULAR PATIENTS
by: Yu. I. Gurfinkel, et al.
Published: (2009-04-01)

Experimental data on compressive strength and ultrasonic pulse velocity properties of sustainable mortar made with high content of GGBFS and CKD combinations
by: Hasan Sh Majdi, et al.
Published: (2020-08-01)

Peripheral arterial endothelial dysfunction predicts future cardiovascular events in diabetic patients with albuminuria: a prospective cohort study
by: Bo Kyung Koo, et al.
Published: (2020-06-01)

P2.02 PREDICTION OF CARDIOVASCULAR EVENTS: A COMPARISON OF BRACHIAL-ANKLE PULSE WAVE VELOCITY AND CARDIO-ANKLE VASCULAR INDEX
by: I. Orlova, et al.
Published: (2010-12-01)

Arterial pulse waveform and pulse wave velocity
by: Sng, Gabriela Jing Hui
Published: (2023)

Effect of MAFLD on albuminuria and the interaction between MAFLD and diabetes on albuminuria
by: Yufang Liu, et al.
Published: (2024-02-01)

Assessment of pulse wave velocity
by: Pierre Boutouyrie, et al.
Published: (2008-12-01)

Pulse Wave Velocity in Atherosclerosis
by: Hack-Lyoung Kim, et al.
Published: (2019-04-01)

Albuminuria as a Predictor of Cardiovascular Outcomes in Patients With Acute Myocardial Infarction
by: Yejin Mok, et al.
Published: (2019-04-01)

2.5 COMPARISON OF NON-INVASIVE AND INVASIVE MEASUREMENTS OF CENTRAL BLOOD PRESSURE IN PATIENTS WITH CHRONIC KIDNEY DISEASE
by: R. Carlsen, et al.
Published: (2014-11-01)

Association of Circulating Platelet Extracellular Vesicles and Pulse Wave Velocity with Cardiovascular Risk Estimation
by: Leslie Marisol Lugo-Gavidia, et al.
Published: (2022-09-01)

FGF23 and Phosphate–Cardiovascular Toxins in CKD
by: Isabel Vogt, et al.
Published: (2019-11-01)

Brachial‐ankle pulse wave velocity and cardio‐ankle vascular index are associated with future cardiovascular events in a general population: The Nagahama Study
by: Tabara Yasuharu, et al.
Published: (2021-07-01)

3.7 PULSE WAVE VELOCITY IS AN INDEPENDENT RISK FACTOR FOR CARDIOVASCULAR EVENTS, MORTALITY AND DECLINE IN RENAL FUNCTION IN PATIENTS WITH TYPE 1 DIABETES
by: Tine Willum Hansen, et al.
Published: (2018-12-01)

Albuminuria during treatment with angiotensin type II receptor blocker is a predictor for GFR decline among non-diabetic hypertensive CKD patients.
by: Mi-Yeon Yu, et al.
Published: (2018-01-01)

Protein Biomarkers and Major Cardiovascular Events in Older People With Advanced CKD: The European Quality (EQUAL) Study
by: Samantha J.L. Hayward, et al.
Published: (2024-01-01)

Deoxycholic Acid and Risks of Cardiovascular Events, ESKD, and Mortality in CKD: The CRIC StudyPlain-Language Summary
by: Rebecca Frazier, et al.
Published: (2022-01-01)

Effects of calcium-containing phosphate binders on cardiovascular events and mortality in predialysis CKD stage 5 patients.
by: Ping-Huang Tsai, et al.
Published: (2020-01-01)

Pulse Wave Analysis and Pulse Wave Velocity for Fistula Assessment
by: Niklas Mueller, et al.
Published: (2020-06-01)